Background: Individuals with obesity who use glucagon-like peptide 1 receptor agonists (GLP-1s) for weight loss are often judged for taking a "shortcut" rather than using "optimal" methods (i.e., diet/exercise). This is linke... ...

请注册登录后继续浏览